Steven Cohen's EW Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.83 M shares of Edwards Lifesciences Corporation (EW) worth $146.27 M, representing 0.19% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in EW, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2024, adding 2.97 M shares. Largest reduction occurred in Q2 2024, reducing 2.53 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Edwards Lifesciences Corporation (EW) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edwards Lifesciences Corporation (EW) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.38 M | Add 311.04% | 1.83 M | $80.08 |
| Q4 2025 | -287,691 | Reduce 39.30% | 444,367 | $85.25 |
| Q3 2025 | -2.31 M | Reduce 75.91% | 732,058 | $77.77 |
| Q2 2025 | +1.57 M | Add 106.94% | 3.04 M | $78.21 |
| Q1 2025 | +880,527 | Add 149.70% | 1.47 M | $72.48 |
| Q4 2024 | +588,206 | New Buy | 588,206 | $74.03 |
| Q3 2024 | -444,162 | Sold Out | 0 | $0.00 |
| Q2 2024 | -2.53 M | Reduce 85.05% | 444,162 | $92.37 |
| Q1 2024 | +2.97 M | New Buy | 2.97 M | $95.56 |
| Q4 2023 | -22,199 | Sold Out | 0 | $0.00 |
| Q3 2023 | +22,199 | New Buy | 22,199 | $69.28 |
| Q2 2023 | -385 | Sold Out | 0 | $0.00 |
| Q1 2023 | +385 | New Buy | 385 | $82.68 |
| Q2 2021 | -579,142 | Sold Out | 0 | $0.00 |
| Q1 2021 | +579,142 | New Buy | 579,142 | $83.64 |
| Q4 2020 | -119,415 | Sold Out | 0 | $0.00 |
| Q3 2020 | -367,269 | Reduce 75.46% | 119,415 | $79.82 |
| Q2 2020 | +244,137 | Add 100.66% | 486,684 | $69.11 |
| Q1 2020 | +164,112 | Add 209.23% | 242,547 | $62.87 |
| Q4 2019 | -75,888 | Reduce 49.17% | 78,435 | $77.76 |
| Q3 2019 | +120,120 | Add 351.20% | 154,323 | $73.30 |
| Q2 2019 | -130,857 | Reduce 79.28% | 34,203 | $61.57 |
| Q1 2019 | -33,540 | Reduce 16.89% | 165,060 | $63.78 |
| Q4 2018 | +184,800 | Add 1339.13% | 198,600 | $51.06 |
| Q3 2018 | +13,800 | New Buy | 13,800 | $58.04 |
| Q2 2018 | -600,000 | Sold Out | 0 | $0.00 |
| Q1 2018 | +210,000 | Add 53.85% | 600,000 | $46.51 |
| Q4 2017 | -1.03 M | Reduce 72.60% | 390,000 | $37.57 |
| Q3 2017 | +84,285 | Add 6.29% | 1.42 M | $36.44 |
| Q2 2017 | +999,975 | Add 294.78% | 1.34 M | $39.41 |
| Q1 2017 | -1.09 M | Reduce 76.26% | 339,225 | $31.36 |
| Q4 2016 | +415,500 | Add 40.99% | 1.43 M | $31.23 |
| Q3 2016 | +431,100 | Add 74.00% | 1.01 M | $40.19 |
| Q2 2016 | +541,500 | Add 1317.52% | 582,600 | $33.24 |
| Q1 2016 | -408,300 | Reduce 90.85% | 41,100 | $29.39 |
| Q4 2015 | -949,800 | Reduce 67.88% | 449,400 | $26.33 |
| Q3 2015 | +360,000 | Add 34.64% | 1.4 M | $23.69 |
| Q2 2015 | -397,200 | Reduce 27.65% | 1.04 M | $23.74 |
| Q1 2015 | +1.44 M | New Buy | 1.44 M | $23.74 |
| Q4 2014 | -1.24 M | Sold Out | 0 | $0.00 |
| Q3 2014 | +1.24 M | New Buy | 1.24 M | $17.03 |
Steven Cohen's Edwards Lifesciences Corporation Investment FAQs
Steven Cohen first purchased Edwards Lifesciences Corporation (EW) in Q3 2014, acquiring 1,237,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Edwards Lifesciences Corporation (EW) for 41 quarters since Q3 2014.
Steven Cohen's largest addition to Edwards Lifesciences Corporation (EW) was in Q1 2024, adding 2,970,804 shares worth $283.89 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,826,537 shares of Edwards Lifesciences Corporation (EW), valued at approximately $146.27 M.
As of the Q1 2026 filing, Edwards Lifesciences Corporation (EW) represents approximately 0.19% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Edwards Lifesciences Corporation (EW) was 3,039,381 shares, as reported at the end of Q2 2025.